Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

EGFR gene mutation study in cytology specimens.

Acta cytologica - 1 Jan 2012

Ma Edmond S K, Ng Wai-Kuen, Wong Chris L P

Abstract excerpt

Activating mutations of the epidermal growth factor receptor (EGFR) gene in non-small cell lung cancer predicts a significantly higher clinical response rate to tyrosine kinase inhibitors targeting EGFR, and it is currently recommended that patients under consideration for EGFR TKI as first-line therapy be tested for such mutations to determine the appropriateness of treatment. For lung cancer patients who...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Mutation
Share to Prognosis
Share to Cytodiagnosis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to ErbB Receptors

Share to EGFR gene

Share to Lung Neoplasms

Source

Identifiers

PMID: 23207445
DOI: 10.1159/000343606

Genes

EGFR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

EGFR gene mutation study in cytology specimens.PMID 23207445Read ↗

Evaluation of EGFR mutation status in cytology specimens: an institutional experience.Semantic proximity Read ↗

EGFR and KRAS mutations in lung carcinoma: molecular testing by using cytology specimens.Semantic proximity Read ↗

Comparison of Confirmed Cytology Smears and Cell Blocks for Epidermal Growth Factor Receptor Mutation Testing in Non-Small Cell Lung Cancer.Semantic proximity Read ↗

Use of Exfoliative Specimens and Fine-Needle Aspiration Smears for Mutation Testing in Lung Adenocarcinoma.Semantic proximity Read ↗

EGFR mutation testing in lung cancer: a review of available methods and their use for analysis of tumour tissue and cytology samples.Semantic proximity Read ↗

EGFR analysis: current evidence and future directions.Semantic proximity Read ↗

Cytology‐based gene mutation tests to predict response to anti‐epidermal growth factor receptor therapy: A reviewSemantic proximity Read ↗

Importance of the cytological samples for the epidermal growth factor receptor gene mutation test for non-small cell lung cancer.Semantic proximity Read ↗

EGFR mutations are detected comparably in cytologic and surgical pathology specimens of nonsmall cell lung cancer.Semantic proximity Read ↗

EGFR mutation testing using archival-stained smears in non-small cell lung carcinoma.Semantic proximity Read ↗

EGFR and KRAS mutation analysis in cytologic samples of lung adenocarcinoma enabled by laser capture microdissection.Semantic proximity Read ↗

EGFR mutations detected on cytology samples by a centralized laboratory reliably predict response to gefitinib in non-small cell lung carcinoma patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.